These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 35934321

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
    Dieckmann KP, Radtke A, Spiekermann M, Balks T, Matthies C, Becker P, Ruf C, Oing C, Oechsle K, Bokemeyer C, Hammel J, Melchior S, Wosniok W, Belge G.
    Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.
    Konneh B, Lafin JT, Howard J, Gerald T, Amini A, Savelyeva A, Woldu SL, Lewis CM, Jia L, Margulis V, Coleman N, Scarpini C, Frazier AL, Murray MJ, Amatruda JF, Bagrodia A.
    Andrology; 2023 May; 11(4):634-640. PubMed ID: 36254623
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Micro-RNA-371a-3p in Germ Cell Testicular Tumors on Diagnosis: A Prospective Case-Control Study in Turkish Population.
    Kılınç MT, Göger YE, Özkent MS, Kılıç Ö, Okur Altındaş B, Yıldırım MS, Karalezli G.
    Urol J; 2024 Jun 09; 21(4):242-249. PubMed ID: 38629199
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, Dieckmann KP.
    Andrology; 2015 Jan 09; 3(1):78-84. PubMed ID: 25187505
    [Abstract] [Full Text] [Related]

  • 7. Perioperative Serum MicroRNA 371a-3p and 372-3p Levels in Patients with Clinically Localized Testicular Masses.
    Matulewicz RS, Baky F, Knezevic A, Sheinfeld J, Williams BM, Kantor RE, Liso N, Hossain J, Bromberg M, Valentino A, So R, Funt SA, Ye F, Feldman DR.
    Eur Urol Open Sci; 2024 Oct 09; 68():1-9. PubMed ID: 39257620
    [Abstract] [Full Text] [Related]

  • 8. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
    Radtke A, Cremers JF, Kliesch S, Riek S, Junker K, Mohamed SA, Anheuser P, Belge G, Dieckmann KP.
    J Cancer Res Clin Oncol; 2017 Nov 09; 143(11):2383-2392. PubMed ID: 28819887
    [Abstract] [Full Text] [Related]

  • 9. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
    Murray MJ, Bell E, Raby KL, Rijlaarsdam MA, Gillis AJ, Looijenga LH, Brown H, Destenaves B, Nicholson JC, Coleman N.
    Br J Cancer; 2016 Jan 19; 114(2):151-62. PubMed ID: 26671749
    [Abstract] [Full Text] [Related]

  • 10. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
    Badia RR, Abe D, Wong D, Singla N, Savelyeva A, Chertack N, Woldu SL, Lotan Y, Mauck R, Ouyang D, Meng X, Lewis CM, Majmudar K, Jia L, Kapur P, Xu L, Frazier AL, Margulis V, Strand DW, Coleman N, Murray MJ, Amatruda JF, Lafin JT, Bagrodia A.
    J Urol; 2021 Jan 19; 205(1):137-144. PubMed ID: 32856980
    [Abstract] [Full Text] [Related]

  • 11. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
    Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J.
    J Urol; 2015 Jan 19; 193(1):331-7. PubMed ID: 25046619
    [Abstract] [Full Text] [Related]

  • 12. Clinical utility of plasma miR-371a-3p in germ cell tumors.
    Mego M, van Agthoven T, Gronesova P, Chovanec M, Miskovska V, Mardiak J, Looijenga LHJ.
    J Cell Mol Med; 2019 Feb 19; 23(2):1128-1136. PubMed ID: 30536846
    [Abstract] [Full Text] [Related]

  • 13. Refining the serum miR-371a-3p test for viable germ cell tumor detection.
    Lafin JT, Scarpini CG, Amini A, Konneh B, Howard JM, Gerald T, Nuno M, Piao J, Savelyeva A, Wang Z, Gagan J, Jia L, Lewis CM, Murray S, Sawa YC, Margulis V, Woldu SL, Strand DW, Coleman N, Amatruda JF, Frazier AL, Murray MJ, Bagrodia A.
    Sci Rep; 2023 Jun 29; 13(1):10558. PubMed ID: 37386046
    [Abstract] [Full Text] [Related]

  • 14. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP, Radtke A, Geczi L, Matthies C, Anheuser P, Eckardt U, Sommer J, Zengerling F, Trenti E, Pichler R, Belz H, Zastrow S, Winter A, Melchior S, Hammel J, Kranz J, Bolten M, Krege S, Haben B, Loidl W, Ruf CG, Heinzelbecker J, Heidenreich A, Cremers JF, Oing C, Hermanns T, Fankhauser CD, Gillessen S, Reichegger H, Cathomas R, Pichler M, Hentrich M, Eredics K, Lorch A, Wülfing C, Peine S, Wosniok W, Bokemeyer C, Belge G.
    J Clin Oncol; 2019 Jun 01; 37(16):1412-1423. PubMed ID: 30875280
    [Abstract] [Full Text] [Related]

  • 15. Utility of Serum miR-371a-3p in Predicting Relapse on Surveillance in Patients with Clinical Stage I Testicular Germ Cell Cancer.
    Lobo J, Leão R, Gillis AJM, van den Berg A, Anson-Cartwright L, Atenafu EG, Kuhathaas K, Chung P, Hansen A, Bedard PL, Jewett MAS, Warde P, O'Malley M, Sweet J, Looijenga LHJ, Hamilton RJ.
    Eur Urol Oncol; 2021 Jun 01; 4(3):483-491. PubMed ID: 33288479
    [Abstract] [Full Text] [Related]

  • 16. microRNA-371a-3p as informative biomarker for the follow-up of testicular germ cell cancer patients.
    van Agthoven T, Eijkenboom WMH, Looijenga LHJ.
    Cell Oncol (Dordr); 2017 Aug 01; 40(4):379-388. PubMed ID: 28612337
    [Abstract] [Full Text] [Related]

  • 17. Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review.
    Leão R, Albersen M, Looijenga LHJ, Tandstad T, Kollmannsberger C, Murray MJ, Culine S, Coleman N, Belge G, Hamilton RJ, Dieckmann KP.
    Eur Urol; 2021 Oct 01; 80(4):456-466. PubMed ID: 34175151
    [Abstract] [Full Text] [Related]

  • 18. The Diagnostic Accuracy of miR-371a-3p for Testicular Germ Cell Tumors: A Systematic Review and Meta-Analysis.
    Liu Q, Lian Q, Lv H, Zhang X, Zhou F.
    Mol Diagn Ther; 2021 May 01; 25(3):273-281. PubMed ID: 33886084
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid.
    Dieckmann KP, Spiekermann M, Balks T, Ikogho R, Anheuser P, Wosniok W, Loening T, Bullerdiek J, Belge G.
    Urol Int; 2016 May 01; 97(1):76-83. PubMed ID: 26989896
    [Abstract] [Full Text] [Related]

  • 20. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.
    Int J Mol Sci; 2018 Oct 12; 19(10):. PubMed ID: 30321995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.